SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Deel strikes multi-year deal with Arsenal as tech firm enters global sport

Jensen Huang’s quiet role emerges as Argamani describes Nvidia’s two-year vigil for Avinatan Or

Freed Nvidia engineer Avinatan Or meets Jensen Huang at U.S. headquarters

Palo Alto Networks: Hamas-linked hackers launch stealth espionage push across Arab governments

Buzz

Most popular

Daily

Weekly

1

Oracle’s stock has fallen 40% since Safra Catz announced her exit. Its latest earnings didn’t calm investors.

2

Freed Nvidia engineer Avinatan Or meets Jensen Huang at U.S. headquarters

3

After over $390 million in funding, Believer Meats abruptly shuts down

4

Breaking down the resurgence of M&As in times of economic uncertainty

5

Quantum Art raises $100 million Series A to scale full-stack quantum systems

Chiasma

1 stories about Chiasma

נאסד"ק וול סטריט

Nasdaq-Listed Biopharma Company Chiasma Raises $34.5 Million in Public Offering

Chiasma develops octreotide capsules for the treatment of acromegaly, a rare, chronic disease typically caused by a benign tumor of the pituitary gland